Physician profile
Anne C Ames
NPI 1083652101
$964.55
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.78 · 2020: $226 · 2021: $194 · 2022: $450.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $187.65 | 2022 | |
| Abbvie INC. | $147.78 | 2021-2022 | |
| Osteomed LLC | $134.96 | 2019-2020 | |
| Horizon Therapeutics Plc | $115.92 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $112.02 | 2020-2022 | |
| Triad Life Sciences INC. | $66.12 | 2021-2022 | |
| Stryker Corporation | $45.22 | 2022 | |
| Orthofix Medical, INC. | $36.44 | 2019-2020 | |
| Smith+Nephew, INC. | $20.70 | 2020 | |
| Medimetriks Pharmaceuticals, INC. | $19.84 | 2020 | |
| Bolton Medical INC | $17.98 | 2021 | |
| Vertiflex, INC. | $14.20 | 2019 | |
| Melinta Therapeutics, LLC | $11.92 | 2019 | |
| Tactile Systems Technology INC | $11.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.18 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $11.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Ames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.